Risk Management & Pharmacovigilance

UBC - July 30, 2014
Recently, Annette Stemhagen, DrPH, FISPE, Sr. Vice President, Safety, Epidemiology, Risk Management & Registries, met with PharmaVoice editor Taren Grom to discuss post-approval product safety. As part of the Editor’s Take video...
Tagged in:
UBC - July 23, 2014
FDA mandated Risk Evaluation and Mitigation Strategies (REMS) are often viewed as obstacles to product access.  Having supported more than 100 REMS programs, UBC has a different perspective.  We view REMS programs as paths...
UBC - July 14, 2014
Manufacturers of all sizes can benefit from outsourcing pharmacovigilance activities. The expertise, systems and flexibility provided by a vendor can complement current activities or even provide an entire team without the need to...
Tagged in:
UBC - June 16, 2014
The 50th DIA Annual Meeting, which kicks off today, promises to be a blast. We’re looking forward to presenting some unique abstracts and connecting with industry colleagues at our social event. But the highlight of the event for our...
UBC - June 11, 2014
When you ask UBC employees why they love what they do, their answers speak to the heart of what makes UBC great. Here are the top 8 reasons why UBC employees come to work every day. Developing life-saving medications The clinical...
Tagged in:

Pages